Resistell among TOP 10 best start-ups in Switzerland

Discover how the search for a rapid diagnostic system lies at the heart of tackling antibiotic resistance, a problem which is predicted to kill 10 million people a year by 2050. Resistell is working to create the innovative solutions needed.

The Centers for Disease Control and Prevention (CDC) have outlined the ways in which health departments can prevent the spread of antibiotic resistance. Rapid identification of resistant bacteria is at the heart of their strategy. Resistell is helping to make that a reality.

Bacteria such as Pseudomonas aeruginosa are becoming resistant to the widely used antibiotic Ciprofloxacin (CIP). As resistance like this spreads the pioneering work of Resistell becomes more urgent. See how we’re leading the search for faster and more accurate diagnosis.

First case of super-resistant gonorrhea reported⚠️ The emergence of a strain of ‘super-gonorrhoea’, resistant to existing antibiotics, means that a global medical crisis is closer to becoming a reality. @Resistell are utilising the latest technology to create the speed and accuracy needed to fight back against that crisis.

SNSF NRP 72 Antimicrobial Resistance about Resistell.

Real world testing of Resistell methods is the next step in refining and making actual use of our innovations. Our device produces the resistance profile of a pathogen within a few hours instead of days.

On 02.03.2018 the Resistell team presented at Novel Antimicrobials and AMR Diagnostics conference in Berlin. Our MVP attracted a lot of attention!